D. Lambert

发表

Ketamine: its mechanism(s) of action and unusual clinical uses.

D G Lambert, K. Hirota, D. Lambert, 1996, British journal of anaesthesia.

Omics and anaesthesia: pharmacogenomics, proteomics and metabolomics

D. Lambert, 2016 .

Proteomics and metabolomics

D. Lambert, 2010 .

Proteomics and metabolomics

D. Lambert, 2010 .

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics

D. Lambert, R. De Giorgio, Joaquim Azevedo Neto, 2020, Molecules.

Cholinergic stimulation of insulin release from cloned B-cell lines HIT-T15 and RINm5F

D. Lambert, T. Atkins, 2007, Acta diabetologia latina.

Effects of morphine and its metabolites on opiate receptor binding, cAMP formation and [3H]noradrenaline release from SH-SY5Y cells.

D. Lambert, D. Rowbotham, R. Hirst, 1993, Biochemical pharmacology.

Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

D. Webb, H. Krum, H. Vaudry, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.

D. Lambert, Rachel E. Foreman, R. Guerrini, 2017, Organic & biomolecular chemistry.

H. Vaudry, E. Ohlstein, W. Park, 2015 .

A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects

Benjamin D. Hunt, D. Lambert, L. Ng, 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

Structure–activity relationship study on Tyr9 of urotensin-II(4–11): Identification of a partial agonist of the UT receptor

S. Salvadori, D. Lambert, G. Calo’, 2009, Peptides.

Structure–activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)

S. Salvadori, D. Lambert, G. Calo’, 2008, Peptides.

Role of urotensin II and its receptor in health and disease

D. Lambert, J. McDonald, M. Batuwangala, 2007, Journal of Anesthesia.

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

D. Behm, S. Douglas, S. Salvadori, 2004, European journal of pharmacology.

Abstracts of the Spring Anaesthetic Research Society Meeting (ARS) The Royal College of Anaesthetists, London, UK, April 21–22, 2015

P. J. Devereaux, B. McGrath, R. Pearse, 2015 .

The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

H. Sarau, R. Ames, J. Foley, 2006, British journal of pharmacology.

Orexinergic neurons and barbiturate anesthesia

M. Kudo, A. Matsuki, K. Hirota, 2003, Neuroscience.

Binding of GTPγ[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor

D. Lambert, J. McDonald, 2010, British journal of pharmacology.

Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids

S. Salvadori, D. Lambert, G. Calo’, 2007 .

Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1–14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1–14)NH2

D. Lambert, G. Calo’, R. Guerrini, 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effect of halothane on K+ and carbachol stimulated [3H]noradrenaline release and increased [Ca2+]i in SH-SY5Y human neuroblastoma cells.

D. Lambert, D. Rowbotham, R. Hirst, 1997, British journal of anaesthesia.

Effects of propofol and thiopentone on potassium- and carbachol-evoked [3H]noradrenaline release and increased [Ca2+]i from SH-SY5Y human neuroblastoma cells.

D. Lambert, C. Frost, D. Rowbotham, 1996, Biochemical pharmacology.

Halothane and isoflurane enhance basal and carbachol-stimulated inositol(1,4,5)triphosphate formation in SH-SY5Y human neuroblastoma cells.

D. Lambert, D. Smart, G. Smith, 1994, Biochemical pharmacology.

Hot topics in opioid pharmacology: mixed and biased opioids.

D. Lambert, J. McDonald, Ammar A H Azzam, 2019, British journal of anaesthesia.

In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505

S. Salvadori, C. Ghelardini, D. Lambert, 2018, British journal of pharmacology.

Antagonistic effects of [Nphe1]nociceptin(1–13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese ovary hamster cells stably expressing the recombinant human nociceptin receptor

D. Lambert, G. Calo’, R. Guerrini, 2000, Neuroscience Letters.

Adrenomedullin(16–31) Has Pressor Activity in the Rat But Not the Cat

D. Lambert, H. Champion, P. Kadowitz, 1997, Peptides.

Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat

D. Coy, D. Lambert, H. Champion, 1997, Regulatory Peptides.

Analysis of responses to human synthetic adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat

D. Lambert, H. Champion, P. Kadowitz, 2004, Molecular and Cellular Biochemistry.

Drugs used to treat joint and muscle disease

D. Lambert, 2015 .

Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder

D. Lambert, A. Taylor, D. Tincello, 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

Controlling cancer pain: Is morphine the best we can do?

D. Lambert, D. Rowbotham, N. Dietis, 2011 .

Studies on the binding of [3H]amethocaine to rat cerebrocortical membranes.

T. Kudo, M. Kudo, K. Hirota, 1997, British journal of anaesthesia.

Do local anaesthetics interact with dihydropyridine binding sites on neuronal L-type Ca2+ channels?

K. Hirota, D. Lambert, D. Lambert, 1997, British journal of anaesthesia.

Interaction of i.v. anaesthetic agents with 5-HT3 receptors.

D. Lambert, B. Appadu, 1996, British journal of anaesthesia.

I.v. anaesthetic agents inhibit dihydropyridine binding to L-type voltage-sensitive Ca2+ channels in rat cerebrocortical membranes.

K. Hirota, D. Lambert, 1996, British journal of anaesthesia.

Disease-modifying antirheumatic drugs

David G. Lambert, D. Lambert, 2009 .

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function

N. Samani, J. Thompson, P. Vollenweider, 2013, PloS one.

Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor

D. Lambert, G. Calo’, R. Guerrini, 2018, British journal of pharmacology.

Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.

S. Salvadori, D. Lambert, G. Calo’, 2009, European journal of pharmacology.

Bronchoconstrictive and relaxant effects of lidocaine on the airway in dogs

T. Kudo, A. Matsuki, K. Hirota, 2001, Critical care medicine.

Does cigarette smoking increase plasma urotensin II concentrations?

J. Williams, D. Lambert, Jonathan P Thompson, 2007, European Journal of Clinical Pharmacology.

Drugs and receptors

David G. Lambert, D. Lambert, 2004 .

Radioimmunoassay, enzyme and non-enzyme-based immunoassays.

D. Lambert, J. Thompson, R. D. Grange, 2014, British journal of anaesthesia.

Functional plasticity of the N/OFQ‐NOP receptor system determines analgesic properties of NOP receptor agonists

D. Lambert, W. Schröder, M. Ko, 2014, British journal of pharmacology.

Pharmacogenomics and personalised analgesia

D. Lambert, 2011 .

Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine.

D. Lambert, G. Calo’, R. Guerrini, 2007, American journal of physiology. Heart and circulatory physiology.

Properdin Levels in Human Sepsis

D. Lambert, J. McDonald, Jonathan P Thompson, 2015, Front. Immunol..

In vitro pharmacological characterization of a novel unbiased NOP receptor‐selective nonpeptide agonist AT‐403

D. Lambert, G. Calo’, R. Guerrini, 2017, Pharmacology research & perspectives.

Measurement of [3H]PN200-110 and [125I]omega-conotoxin MVIIA binding.

K. Hirota, D. Lambert, 2006, Methods in molecular biology.

Interaction of neuromuscular blocking drugs with recombinant human m1–m5 muscarinic receptors expressed in Chinese hamster ovary cells

D. Lambert, B. Appadu, M. Tidmarsh, 1998, British journal of pharmacology.

Coupling of the cloned rat κ-opioid receptor to adenylyl cyclase is dependent on receptor expression

D. Grandy, K. Hirota, D. Lambert, 1997, Neuroscience Letters.

Nociceptin system as a target in sepsis?

D. Lambert, Jonathan P Thompson, C. Stover, 2014, Journal of Anesthesia.

Opioids and immune modulation: more questions than answers.

D. Lambert, Jonathan P Thompson, J. Thompson, 2013, British journal of anaesthesia.

Nociceptin/orphanin FQ in inflammation and sepsis.

D. Lambert, J. Thompson, A. Serrano-Gómez, 2011, British journal of anaesthesia.

α‐Adrenoceptor constrictor responses and their modulation in slow‐twitch and fast‐twitch mouse skeletal muscle

D. Lambert, G. Thomas, 2005 .

Insulin release from a cloned hamster B-cell line (HIT-T15). The effects of glucose, amino acids, sulphonylureas and colchicine.

D. Lambert, T. Atkins, K. Hughes, 1986, Biochemical and biophysical research communications.

Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.

D. Lambert, B. Appadu, T. Cembala, 2007, European journal of pharmacology.

Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).

D. Lambert, G. Calo’, R. Guerrini, 2012, British journal of anaesthesia.

The effects of endomorphin‐1 and endomorphin‐2 in CHO cells expressing recombinant μ‐opioid receptors and SH‐SY5Y cells

D. Grandy, D. Lambert, L. Devi, 1999, British journal of pharmacology.

Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.

V. Hruby, S. Salvadori, D. Lambert, 2015, British journal of anaesthesia.

Non-opioid analgesic drugs

D. Lambert, C. Hebbes, 2008 .

Propofol and SARS-CoV-2 infection

K. Hirota, D. Lambert, 2020, British Journal of Anaesthesia.

A novel bioassay to detect Nociceptin/Orphanin FQ release from single human polymorphonuclear cells

D. Lambert, M. Bird, J. Willets, 2022, PloS one.

Orexin A and B evoke noradrenaline release from rat cerebrocortical slices

T. Kudo, M. Kudo, A. Matsuki, 2001, British journal of pharmacology.

Cellular actions of nociceptin: transduction mechanisms

B. Hawes, D. Lambert, M. Graziano, 2000, Peptides.

In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4–11) (UFP‐803)

S. Douglas, S. Salvadori, D. Lambert, 2006, British journal of pharmacology.

Urotensin receptor in GtoPdb v.2021.3

D. Webb, H. Krum, H. Vaudry, 2021, IUPHAR/BPS Guide to Pharmacology CITE.

Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease.

S. P. Young, D. Lambert, J. McDonald, 2009, British journal of anaesthesia.

Urotensin II: from osmoregulation in fish to cardiovascular regulation in man.

D. Lambert, 2007, British journal of anaesthesia.

Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity

D. Lambert, G. Calo’, R. Guerrini, 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

Stimulatory effects of opioids.

D. Lambert, D. Smart, C. Harrison, 1998, British journal of anaesthesia.

Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro

D. Richards, A. Hainsworth, A. Cross, 2001, Neuropharmacology.

Nutrient induced insulin release from an insulinoma derived B-cell line

D. Lambert, T. Atkins, 1987, Acta diabetologia latina.

Immunity and early pregnancy events: are endocannabinoids the missing link?

D. Lambert, M. Maccarrone, S. Quenby, 2012, Journal of reproductive immunology.

Interaction of Intravenous Anesthetics with Recombinant Human M1-M3 Muscarinic Receptors Expressed in Chinese Hamster Ovary Cells

K. Hirota, D. Lambert, Y. Hashimoto, 2002, Anesthesia and analgesia.

Comparison of the effects of [Phe1Ψ(CH2‐NH)Gly2]Nociceptin (1–13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors

D. Lambert, G. Calo’, R. Guerrini, 1999, British journal of pharmacology.

Interaction of ketamine with mu2 opioid receptors in SH-SY5Y human neuroblastoma cells.

K. Hirota, D. Lambert, K. Sikand, 1999, Journal of anesthesia.

Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma

C. Brightling, A. De Angelis, K. Urbanek, 2016, British journal of pharmacology.

On the regulation of ischaemia‐induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone

D. Lambert, A. R. Green, R. M. Nelson, 2000, British journal of pharmacology.

Pharmacology and potential therapeutic uses of cannabis.

D. Lambert, W. Notcutt, R. Hirst, 1998, British journal of anaesthesia.

In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives

S. Salvadori, D. Lambert, C. Ruzza, 2014, British journal of pharmacology.

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues

S. Salvadori, D. Lambert, G. Calo’, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.

D. Lambert, A. Taylor, J. McDonald, 2009, Molecular endocrinology.

Volume 100: basic sciences in the British Journal of Anaesthesia.

D. Lambert, 2008, British journal of anaesthesia.

Fluorescent opioid receptor ligands as tools to study opioid receptor function.

D. Lambert, G. Calo’, R. Guerrini, 2021, Journal of pharmacological and toxicological methods.

Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain

D. Lambert, Ammar A H Azzam, 2021, Expert opinion on drug discovery.

Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults

D. Lambert, G. Calo’, 2020, British Journal of Anaesthesia.

Inhibitory effects of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat.

D. Lambert, H. Champion, P. Kadowitz, 1998, Canadian journal of physiology and pharmacology.

Comparison of the Inhibitory Actions of Angiotensin AT1 Receptor Antagonists in the Peripheral Vascular Bed

D. Lambert, T. Bivalacqua, H. Champion, 1998 .

Analysis of responses to human synthetic adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat.

D. Lambert, H. Champion, P. Kadowitz, 1997 .

[MPR14]-rADM(14-50), a novel analog of adrenomedullin, possesses potent vasodilator activity in the hindlimb vascular bed of the cat.

D. Lambert, H. Champion, P. Kadowitz, 1996, Life Science.

Lack of an interaction between orexinergic and opioid/nociceptinergic systems in rat cerebrocortical slices

T. Kudo, M. Kudo, A. Matsuki, 2003, Neuroscience Letters.

Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system

D. Lambert, D. Rowbotham, J. McDonald, 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors

L. Gentilucci, A. Janecka, D. Lambert, 2022, International journal of molecular sciences.

The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo

C. Reilly, D. Lambert, N. Brown, 2013, PloS one.

Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.

S. Salvadori, D. Lambert, G. Calo’, 2009, Bioorganic & medicinal chemistry.

Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile.

S. Salvadori, D. Lambert, G. Calo’, 2009, British journal of anaesthesia.

Human Peripheral Blood Mononuclear Cells Express Nociceptin/Orphanin FQ, but Not &mgr;, &dgr;, or &kgr; Opioid Receptors

D. Lambert, D. Rowbotham, J. McDonald, 2007, Anesthesia and analgesia.

In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys7,10]N/OFQ(1–13)NH2

D. Lambert, G. Calo’, R. Guerrini, 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In Vitro Studies

D. Lambert, M. Morari, G. Calo’, 2007, Journal of Pharmacology and Experimental Therapeutics.

Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells

D. Lambert, G. Calo’, R. Guerrini, 2003, Neuroscience Letters.

UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPγ35S binding studies

D. Lambert, G. Calo’, R. Guerrini, 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

Comparison of the binding of [3H]nociceptin/orphaninFQ(1–13)NH2, [3H]nociceptin/orphaninFQ(1–17)OH and [125I]Tyr14nociceptin/orphaninFQ(1–17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors

D. Lambert, G. Tóth, J. Farkas, 2002, Neuroscience Letters.

Interaction of local anaesthetic agents with the endogenous norepinephrine transporter in SH-SY5Y human neuroblastoma cells

D. Lambert, D. Rowbotham, A. Heffernan, 2001, Neuroscience Letters.

Etomidate inhibits [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells

K. Hirota, D. Lambert, G. Smith, 1997, Neuroscience Letters.

A comparative study of L-type voltage sensitive Ca2+ channels in rat brain regions and cultured neuronal cells

K. Hirota, D. Lambert, 1997, Neuroscience Letters.

I.v. anaesthetic agents do not interact with the verapamil binding site on L-type voltage-sensitive Ca2+ channels.

K. Hirota, D. Lambert, 1996, British journal of anaesthesia.

Adenylyl cyclase in SH-SY5Y human neuroblastoma cells is regulated by intra- and extracellular calcium.

D. Lambert, R. Hirst, David G. Lambert, 1995, Biochemical pharmacology.

[Dmt1]N/OFQ(1–13)‐NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist

S. Salvadori, D. Lambert, P. Molinari, 2012, British journal of pharmacology.

K. Hirota, D. Lambert, 2021, British Journal of Anaesthesia.

Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5‐hydroxytryptamine and noradrenaline release in the rat neocortex

D. Lambert, M. Morari, G. Calo’, 2003, British journal of pharmacology.

Glutamate uptake is not a major target site for anaesthetic agents.

D. Lambert, D. Rowbotham, B. Nicol, 1995, British journal of anaesthesia.

Glutamate receptor-mediated inhibition of l-glutamate efflux from cerebral cortex in vitro

A. Hainsworth, D. Lambert, A. Green, 2006, Brain Research.

Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system

D. Lambert, Jonathan P Thompson, C. Stover, 2014, Peptides.

Tone-Dependent Vasodilator Responses to Proadrenomedullin NH2-Terminal 20 Peptide in the Hindquarters Vascular Bed of the Rat

D. Lambert, H. Champion, P. Kadowitz, 1997, Peptides.

Pharmacological studies on the NOP and opioid receptor agonist PWT2‐[Dmt1]N/OFQ(1‐13)

D. Lambert, C. Ruzza, G. Calo’, 2017, European journal of pharmacology.

Simultaneous targeting of multiple opioid receptor types

D. Lambert, M. Bird, M. F. Bird, 2015, Current opinion in supportive and palliative care.

Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.

S. Salvadori, K. Varani, D. Lambert, 2000, Journal of medicinal chemistry.

Cannabinoids and sepsis

D. Lambert, L. Beishon, N. Ladak, 2011 .

Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.

S. Salvadori, D. Lambert, G. Calo’, 2007, Bioorganic & medicinal chemistry.

Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.

D. Lambert, G. Calo’, R. Guerrini, 2002, European journal of pharmacology.

In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist

D. Lambert, G. Calo’, R. Guerrini, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain

D. Lambert, D. Rowbotham, D. Buggy, 2003, Pain.

Mixed mu-nociceptin/orphanin FQ opioid receptor agonists and the search for the analgesic holy grail.

D. Lambert, 2019, British journal of anaesthesia.

Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist

S. Salvadori, D. Lambert, G. Calo’, 2000, British journal of pharmacology.

Drugs used to treat muscle and joint disease

D. Lambert, 2012 .

Does propofol interact with D2 dopamine receptors

D. Lambert, P. Strange, B. Appadu, 1994 .

Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit.

D. Lambert, T. Bivalacqua, H. Champion, 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit.

D. Lambert, T. Bivalacqua, H. Champion, 1999, The American journal of physiology.

Nociceptin/Orphanin FQ

D. Lambert, G. Calo’, R. Guerrini, 2013 .

Ketamine and depression.

K. Hirota, D. Lambert, 2018, British journal of anaesthesia.

Nociceptin/orphanin FQ in inﬂammation and sepsis

D. Lambert, A. Serrano-Gómez, J. P. Thompson, 2010 .

Human Peripheral Blood Mononuclear Cells Produce Pre-Pro-Nociceptin/Orphanin FQ mRNA

D. Lambert, D. Rowbotham, Jonathan P Thompson, 2008, Anesthesia and analgesia.

Opioid mechanisms and opioid drugs

D. Lambert, J. McDonald, 2008 .

Mechanisms of action of general anaesthetic drugs

D. Lambert, 2011, Anaesthesia & Intensive Care Medicine.

PharmacologyMechanisms of action of general anaesthetic drugs

D. Lambert, 2014 .

Endomorphin 1 and 2, the endogenous mu-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat.

A. Kastin, D. Lambert, T. Bivalacqua, 1998, Life sciences.

Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder

D. Lambert, A. Taylor, D. Tincello, 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells

D. Lambert, G. Calo’, R. Guerrini, 2022, PloS one.

Assessment of nociceptin/orphanin FQ and micro-opioid receptor mRNA in the human right atrium.

S. P. Young, D. Lambert, J. McDonald, 2010, British journal of anaesthesia.

μ‐Opioid Receptor Stimulation of Inositol (1,4,5)Trisphosphate Formation via a Pertussis Toxin‐Sensitive G Protein

D. Lambert, D. Smart, G. Smith, 1994, Journal of neurochemistry.

Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening.

D. Lambert, D. Smart, G. Smith, 1995, The Biochemical journal.

Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices

D. Lambert, D. Rowbotham, D. Smart, 1996, British journal of pharmacology.

MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands

D. Lambert, G. Calo’, R. Guerrini, 2022, PloS one.

Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic

D. Lambert, G. Calo’, David G. Lambert, 2018, British journal of anaesthesia.

Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)

C. Ghelardini, D. Lambert, P. Molinari, 2016, PloS one.

UFP‐112 a Potent and Long‐Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor

Maurizio Massi, Remo Guerrini, Girolamo Calo', 2011, CNS neuroscience & therapeutics.

The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential

David G. Lambert, D. Lambert, 2008, Nature Reviews Drug Discovery.

Pain medicine: advances in basic sciences and clinical practice.

D G Lambert, D. Lambert, L A Colvin, 2008, British journal of anaesthesia.

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist

S. Salvadori, G. Balboni, D. Lambert, 2008, Peptides.

Fentanyl inhibits the uptake of [3H]noradrenaline in cultured neuronal cells.

D. Lambert, D. Rowbotham, R. Atcheson, 1993, British journal of anaesthesia.

Ketamine: new uses for an old drug?

K. Hirota, D. Lambert, 2011, British journal of anaesthesia.

II Ketamine : new uses for an old drug ?

K. Hirota, D. Lambert, 2011 .

Calcium Signaling Protocols

David G. Lambert, D. Lambert, 1999, Methods in Molecular Biology.

Ratiometric [Ca²⁺]i measurements in adherent cell-lines using the NOVOstar microplate reader.

Benjamin D. Hunt, D. Lambert, 2013, Methods in molecular biology.

Desensitisation of native and recombinant human urotensin-II receptors

D. Lambert, G. Calo’, R. Guerrini, 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

Activation of recombinant human TRPV1 receptors expressed in SH‐SY5Y human neuroblastoma cells increases [Ca2+]i, initiates neurotransmitter release and promotes delayed cell death

D. Owen, A. Hainsworth, D. Lambert, 2007, Journal of neurochemistry.

Measurement of [Ca2+]i in whole cell suspensions using fura-2.

K. Hirota, D. Lambert, R. Hirst, 2006, Methods in molecular biology.

Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.

D. Lambert, J. McDonald, P. Lam, 2005, British journal of anaesthesia.

Measurement of [Ca²+]i in whole cell suspensions using fura-2.

K. Hirota, D. Lambert, R. Hirst, 2005, Methods in molecular biology.

The Effects of Local and Intravenous Anesthetics on Recombinant Rat VR1 Vanilloid Receptors

K. Hirota, D. Lambert, D. Smart, 2003, Anesthesia and analgesia.

Muscarinic receptors coupled to phosphoinositide hydrolysis and elevated cytosolic calcium in a human neuroblastoma cell line SK‐N‐SH

D. Lambert, S. Nahorski, D. Lambert, 1989, British journal of pharmacology.

Opioid receptor subtypes: fact or artifact?

D. Lambert, D. Rowbotham, Nikolaos Dietis, 2011, British journal of anaesthesia.

Nociceptin and urotensin-II concentrations in critically ill patients with sepsis.

S. P. Young, J. Williams, D. Lambert, 2008, British journal of anaesthesia.

Regulation of Muscarinic Agonist‐Induced Activation of Phosphoinositidase C in Electrically Permeabilized SH‐SY5Y Human Neuroblastoma Cells by Guanine Nucleotides

R. Wojcikiewicz, D. Lambert, S. Nahorski, 1990, Journal of neurochemistry.

Effects of intravenous and local anesthetic agents on ω-conotoxin MVIIA binding to rat cerebrocortex

K. Hirota, D. Lambert, 2000 .

Update on opioid receptors.

D. Lambert, R. Atcheson, 1994, British journal of anaesthesia.

Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor

D. Lambert, G. Calo’, R. Guerrini, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Opioids and the neuroimmune axis.

D G Lambert, J P Williams, J. Williams, 2005, British journal of anaesthesia.

Nocistatin reverses nociceptin inhibition of glutamate release from rat brain slices.

D. Lambert, E. Okuda‐Ashitaka, S. Ito, 1998, European journal of pharmacology.

Identification of nociceptin in human cerebrospinal fluid: comparison of levels in pain and non-pain states

D. Lambert, D. Rowbotham, D. Smart, 1998, Pain.

Orphanin FQ/nociceptin: an endogenous peptide agonist for the orphan opioid receptor.

D. Grandy, D. Lambert, 1998, British journal of anaesthesia.

Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation

D. Lambert, D. Smart, R. Hirst, 1998, Neuroscience Letters.

Effect of Lidocaine on cAMP Formation with Recombinant Opioid Receptors Expressed in Chinese Hamster Ovary Cells

D. Grandy, K. Hirota, D. Lambert, 1998 .

Voltage-sensitive Ca2+ channels and anaesthesia.

K. Hirota, D. Lambert, 1996, British journal of anaesthesia.

Muscarinic receptor subtypes: do they have a place in clinical anaesthesia?

D. Lambert, B. Appadu, 1995, British journal of anaesthesia.

Inhibitory effects of intravenous anaesthetic agents on K+-evoked norepinephrine and dopamine release from rat striatal slices: possible involvement of P/Q-type voltage-sensitive Ca2+ channels.

T. Kudo, M. Kudo, K. Hirota, 2000, British journal of anaesthesia.

The stimulatory effects of opioids and their possible role in the development of tolerance.

D. Lambert, D. Smart, D. Smart, 1996, Trends in pharmacological sciences.

Evidence for nociceptin/orphanin FQ (NOP) but not µ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood.

D. Lambert, J. McDonald, J. Thompson, 2016, British journal of anaesthesia.

Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene.

D. Lambert, P. Doran, D. Murray, 2011, British journal of anaesthesia.

Endomorphin‐1 induced desensitization and down‐regulation of the recombinant μ‐opioid receptor

D. Lambert, D. Rowbotham, C. Harrison, 2000, British journal of pharmacology.

Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.

D. Lambert, D. Rowbotham, D. Buggy, 2003, Pain.

Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.

D. Lambert, G. Calo’, R. Guerrini, 2002, European journal of pharmacology.

Evaluation of primary opioid receptor antibodies for use in western blotting.

D. Lambert, D. Rowbotham, H. Niwa, 2012, British journal of anaesthesia.

Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed.

D. Lambert, T. Bivalacqua, H. Champion, 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

Effects of Intravenous Anesthetic Agents on Glutamate Release: A Role for GABAA Receptor–Mediated Inhibition

D. Lambert, D. Rowbotham, D. Buggy, 2000, Anesthesiology.

Opioids and neovascularization; pro or anti?

D. Lambert, W. Mahbuba, 2015, British journal of anaesthesia.

Stereoselective Interaction of Ketamine with Recombinant [micro sign], [small kappa, Greek], and [small delta, Greek] Opioid Receptors Expressed in Chinese Hamster Ovary Cells

Lakshmi A. Devi, David G. Lambert, K. Hirota, 1999 .

Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

D G Lambert, H Okawa, D. Grandy, 1999, Anesthesiology.

Capsaicin receptor antagonists: a promising new addition to the pain clinic.

D. Lambert, 2009, British journal of anaesthesia.

Nimodipine premedication and induction dose of propofol.

D J Buggy, M J Asher, D G Lambert, 2000, Anesthesia and analgesia.

Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?

D. Lambert, D. Rowbotham, D. Buggy, 2013, Journal of Anesthesia.

Studies on the interaction of steroidal neuromuscular blocking drugs with cardiac muscarinic receptors.

D. Lambert, B. Appadu, 1994, British journal of anaesthesia.

Ketamine inhibits K+ evoked [3H] noradrenaline release from SH-SY5Y cells by reducing calcium influx.

D. Lambert, G. Smith, K. Sikand, 1995, Biochemical Society transactions.

Perioperative medicine and UK plc.

D. Lambert, B. Shelley, H. Galley, 2019, British journal of anaesthesia.

Interaction of local anaesthetics with recombinant μ, κ, and δ opioid receptors expressed in Chinese hamster ovary cells

David G. Lambert, K. Hirota, Hirobumi Okawa, 2000 .

Does propofol interact with D2 dopamine receptors?

D. Lambert, P. Strange, B. Appadu, 1994, Anesthesia and analgesia.

International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

Jérôme Leprince, Hubert Vaudry, Eliot H. Ohlstein, 2015, Pharmacological Reviews.

Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli

D. Lambert, G. Calo’, R. Guerrini, 2022, BJA open.

Characterisation of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamine

D. Lambert, J. Traynor, D. Smart, 1994 .

In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands

Benjamin D. Hunt, D. Lambert, L. Ng, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacology of ischemia-induced glutamate efflux from rat cerebral cortex in vitro

A. Hainsworth, D. Lambert, A. Green, 2003, Brain Research.

Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells?

D. J. Campbell, D. Lambert, D. Rowbotham, 1995, British journal of anaesthesia.

Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population.

J. Davies, A. Hainsworth, D. Lambert, 2010, British journal of anaesthesia.

The Nociceptin/Orphanin FQ System Is Modulated in Patients Admitted to ICU with Sepsis and after Cardiopulmonary Bypass

D. Lambert, J. McDonald, N. Ladak, 2013, PloS one.

Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?

D. Lambert, 2020, British Journal of Anaesthesia.

Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors

D. Lambert, G. Calo’, R. Guerrini, 2021, PloS one.

Non-opioid analgesics

D. Lambert, C. Hebbes, 2011 .

Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats

D. Lambert, R. Mason, Y. Mbaki, 2016, International Urogynecology Journal.

Long-term activation of polymorph cannabinoid receptors does not affect receptor gene transcription.

D. Lambert, L. Beishon, J. McDonald, 2014, British journal of anaesthesia.

The effects of recombinant rat μ‐opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase

K. Hirota, D. Lambert, D. Smart, 1997, British journal of pharmacology.

S18 Activation of nociceptin orphanin FQ (N/OFQ) – N/OFQ peptide (NOP) receptor system plays a key immunomodulatory role in asthma

K. Urbanek, D. Lambert, G. Calo’, 2013, Thorax.

Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist

David G. Lambert, D. Lambert, R. Hirst, 1996, Neuroscience Letters.

The effect of C-terminal truncation of the recombinant δ-opioid receptor on Cai2+ signaling

D. Lambert, L. Devi, D. Rowbotham, 1999 .

[Nphe1,Arg14,Lys15]Nociceptin‐NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor

S. Salvadori, D. Lambert, M. Morari, 2002, British journal of pharmacology.

Fentanyl increases intracellular Ca2+ concentrations in SH-SY5Y cells.

D. Lambert, D. Smart, A. Wandless, 1996, British journal of anaesthesia.

Signal transduction: G proteins and second messengers.

D. Lambert, David G. Lambert, 1993, British journal of anaesthesia.

Cannabinoid receptor expression in the bladder is altered in detrusor overactivity

D. Lambert, J. McDonald, D. Tincello, 2015, International Urogynecology Journal.

Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system

J. Williams, D. Lambert, G. Calo’, 2003, British journal of pharmacology.

Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.

D. Lambert, D. Rowbotham, D. Smart, 2001, European journal of pharmacology.

The Effect of Guanethidine and Local Anesthetics on the Electrically Stimulated Mouse Vas Deferens

D. Lambert, G. Calo’, D. Rowbotham, 2002, Anesthesia and analgesia.

Measurement of [Ca²⁺]i in whole cell suspensions using Fura-2.

K. Hirota, D. Lambert, R. Hirst, 2013, Methods in molecular biology.

Measurement of [Ca2+]i in whole cell suspensions using fura-2.

K. Hirota, D. Lambert, R. Hirst, 1999, Methods in molecular biology.

Effects of morphine on human nasal cilia beat frequency in vitro.

D. Lambert, J. Raphael, J. Langton, 1996, British journal of anaesthesia.

Opioids, gliosis and central immunomodulation

D. Lambert, J. McDonald, S. Kadhim, 2018, Journal of Anesthesia.

The effects of nociceptin peptide (N/OFQ)–receptor (NOP) system activation in the airways

C. Brightling, D. Lambert, B. D'Agostino, 2013, Peptides.

Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist.

D. Lambert, D. Rowbotham, M. Bird, 2015, British journal of anaesthesia.

UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.

S. Salvadori, D. Lambert, G. Calo’, 2006, CNS drug reviews.

UFP-101, a Peptide Antagonist Selective for the Nociceptin (cid:1) Orphanin FQ Receptor

S. Salvadori, D. Lambert, G. Calo’, 2005 .

Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic?

D G Lambert, T A Barnes, D. Lambert, 2004, British journal of anaesthesia.

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

S. Salvadori, D. Lambert, M. Morari, 2005, Journal of Pharmacology and Experimental Therapeutics.

N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.

S. Salvadori, D. Lambert, G. Calo’, 2005, Journal of medicinal chemistry.

Girolamo Calo ’ Pharmacological characterisation of [ ( pX ) Phe 4 ] nociceptin ( 1-13 ) amide analogues 1 . In vitro studies

Hartmut Berger, Remo Guerrini, Girolamo Calo', 2002 .

Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.

S. Salvadori, K. Varani, D. Lambert, 2001, Journal of medicinal chemistry.

Binding of the novel radioligand [3H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors

D. Lambert, G. Calo’, R. Guerrini, 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist.

S. Salvadori, D. Lambert, G. Calo’, 2006, Bioorganic & medicinal chemistry.

Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.

D G Lambert, R Bigoni, G Caò, 2002, Canadian journal of physiology and pharmacology.

Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.

S. Salvadori, D. Lambert, G. Calo’, 2015, Bioorganic & medicinal chemistry.

Effects of nociceptinNH2 and [Nphe1]nociceptin(1–13)NH2 on rat brain noradrenaline release in vivo and in vitro

T. Kudo, M. Kudo, A. Matsuki, 2001, Neuroscience Letters.

Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinoma.

D. Lambert, A. Taylor, E. Moss, 2015, Molecular human reproduction.

Measurement of [³H]PN200-110 and [¹²⁵I]ω-conotoxin MVIIA binding.

K. Hirota, D. Lambert, 2005, Methods in molecular biology.

Fentanyl inhibits the release of [3H]noradrenaline from SH-SY5Y human neuroblastoma cells.

D. Lambert, D. Rowbotham, R. Atcheson, 1994, British journal of anaesthesia.

Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.

D. Lambert, J. Wichmann, F. Jenck, 2002, Life sciences.

Elevation of cytosolic calcium by cholinoceptor agonists in SH‐SY5Y human neuroblastoma cells: estimation of the contribution of voltage‐dependent currents

I. Forsythe, P. Linsdell, D. Lambert, 1992, British journal of pharmacology.

Muscarinic receptors, phosphoinositide metabolism and intracellular calcium in neuronal cells

E. Whitham, R. Wojcikiewicz, D. Lambert, 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation

L. Gentilucci, A. Janecka, D. Lambert, 2020, Molecules.

Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis

D. Lambert, 2023, BJA open.

Characterization of Nociceptin/Orphanin FQ Binding Sites in Dog Brain Membranes

Helen Gibson, David G Lambert, Judit Farkas, 2003, Anesthesia and analgesia.

Tyr-D-Arg2-Phe-sarcosine4 activates phospholipase C-coupled mu2-opioid receptors in SH-SY5Y cells.

D. Lambert, D. Smart, 1996, European journal of pharmacology.

[Peripheral effects of ligands of ORL1 receptors].

D. Lambert, G. Calo’, L. Maslov, 2003, Eksperimental'naia i klinicheskaia farmakologiia.

A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study

D. Lambert, Jonathan P Thompson, P. Watt, 2003, Anesthesia and analgesia.

Molecular pharmacology of the opioid/nociceptin system

D. Lambert, Emma E. Johnson, E. Johnson, 2002 .

Effects of C‐Terminal Truncation of the Recombinant δ‐Opioid Receptor on Phospholipase C and Adenylyl Cyclase Coupling

D. Lambert, L. Devi, D. Smart, 1998, Journal of neurochemistry.

Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies

S. Salvadori, G. Balboni, D. Lambert, 2006, Peptides.

Mu-opioid activation of phospholipase C in SH-SY5Y cells rapidly desensitizes: mechanistic studies.

D. Lambert, D. Smart, 1995, Biochemical Society transactions.

Analgesia induced by metoclopramide.

D. Lambert, B. Appadu, 1993, British journal of anaesthesia.

Interaction of ketamine with μ2 opioid receptors in SH-SY5Y human neuroblastoma cells

K. Hirota, D. Lambert, K. Sikand, 1999, Journal of Anesthesia.

Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine.

D. Lambert, D. Smart, J. Elliott, 1994, European journal of pharmacology.

{alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle.

D. Lambert, G. Thomas, 2005, The Journal of physiology.

In vitro sepsis up‐regulates Nociceptin/Orphanin FQ receptor expression and function on human T‐ but not B‐cells

D. Lambert, G. Calo’, R. Guerrini, 2023, British journal of pharmacology.

Characterisation of a new human neuroblastoma cell line, NAL-GT

D. Lambert, 1995, Neuroscience Letters.

Carbachol stimulated cAMP formation in SH-SY5Y cells is dependent on both extracellular and intracellular calcium.

D. Lambert, R. Hirst, 1993, Biochemical Society Transactions.

N/OFQ-NOP System in Peripheral and Central Immunomodulation.

D. Lambert, M. Bird, S. Kadhim, 2019, Handbook of experimental pharmacology.

Anaesthesia, critical care, and pain in the 21st century: the first decade.

D. Lambert, J. Hardman, 2011, British journal of anaesthesia.

Interaction of local anaesthetics with recombinant mu, kappa, and delta-opioid receptors expressed in Chinese hamster ovary cells.

D. Grandy, K. Hirota, D. Lambert, 2000, British journal of anaesthesia.

Mitochondrial pharmacology turns its sights on the Ca2+ uniporter

D. Lambert, N. Storey, 2017, Cell Death Discovery.

μ- and κ-opioids inhibit K+ evoked glutamate release from rat cerebrocortical slices

D. Lambert, D. Rowbotham, B. Nicol, 1996, Neuroscience Letters.

Nociceptin/orphanin FQ inhibits ischaemiainduced glutamate efflux from rat cerebrocortical slices

A. Hainsworth, D. Lambert, G. Calo’, 2000, Neuroreport.

Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opioid receptor agonist

S. Salvadori, G. Balboni, D. Lambert, 2006, European Neuropsychopharmacology.

Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study.

D. Lambert, Jonathan P Thompson, J. Waugh, 2005, British Journal of Anaesthesia.

Urotensin II: from osmoregulation in fish to cardiovascular regulation in man.

D. Lambert, 2007, British journal of anaesthesia.

Pharmacological characterization of the nociceptin / orphanin FQ receptor antagonist SB-612111: in vivo studies

D. Lambert, M. Morari, G. Calo’, 2007 .

binding to rat cerebrocortical membranes

T. Kudo, M. Kudo, D. Lambert, 1998 .

Antidepressants and antipsychotics: anaesthetic implications

D. Lambert, Faisal Rasool, Rahat Ghafoor, 2011 .

The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.

D. Lambert, T. Bivalacqua, H. Champion, 1999, Journal of the American Society of Nephrology : JASN.

Colorectal Distension Responses of Pelvic Nerve Afferents to Noxious Effects of Kappa Opioid Receptor-Selective Agonists on

K. Yamauchi, A. Page, D. Lambert, 2015 .

Nociceptin/orphanin FQ inhibits glutamate release from rat cerebellar and brain stem slices

D. Lambert, D. Rowbotham, B. Nicol, 2002, Neuroscience Letters.

Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes

D. Lambert, R. Guerrini, J. McDonald, 2004, Brain Research.